Device Trial Radar · NCT02776462
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
Last checked: Nov 20, 2026Latest source record: Sep 7, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
321
Actual
Start
Jun 2016
Primary completion
Nov 16, 2017
Study completion Jun 19, 2018
Sponsor
- Lead sponsor
- Oculogica, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 18, 2016
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 5 years, up to 67 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the sensitivity and specificity of an aid in assessment of concussion based on eye-tracking, in comparison to a clinical reference standard appropriate for the Emergency Department (ED) or concussion clinic.
Conditions
- Brain Concussion
- Cerebral Concussion
- Concussion, Intermediate
- Concussion, Mild
- Concussion, Severe
- Trauma, Nervous System
- Craniocerebral Trauma
- Brain Injuries
Interventions
EyeBox CNSDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- A change in metrics of eye movement that enable positive concussion detection using BOX Score.Time frame: Immediately after eye tracking, within 2 weeks of injury
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
SkyRidge Medical Center
Lone Tree, Colorado
Beaver Dam Community Hospital
Beaver Dam, Wisconsin
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.